POINT Biopharma Global Inc
PNT | $13.68 2.63% 0.15% 0
|
(0.0% 1d) (0.0% 1m) (55.5% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (NaN% volume)
Earnings Calendar: 2023-11-13
Market Cap: $ 1,457,867,080
https://www.pointbiopharma.com
Sec Filling | Patents | 74952 employees
POINT Biopharma Global Inc. is a globally focused radiopharmaceutical company building a platform for the clinical development and commercialization of radioligands that fight cancer. POINT Biopharma Global Inc. is combining a portfolio of best-in-class radiopharmaceutical assets, a seasoned management team, expertise in radioisotopes such as Actinium-225 (Ac-225) and Lutetium-177 (Lu-177), and industry-leading manufacturing capabilities and supply chain to revolutionize theragnostic drug development and radioligand commercialization.
cancer
add to watch list Paper trade email alert is off
Press-releases
Lantheus Reports Fourth Quarter and Full Year 2023 Financial Results
Published: 2024-02-22 (Crawled : 12:00) - globenewswire.com
LNTH | News | $63.8 2.36% 2.3% 800K
|
Health Technology
|
| O: 11.09%
H: 4.11%
C: 3.25%
year financial results
Lantheus Reports Preliminary Fiscal Year 2023 Revenue
Published: 2024-01-09 (Crawled : 13:00) - globenewswire.com
LNTH | News | $63.8 2.36% 2.3% 800K
|
Health Technology
|
| O: 0.6%
H: 0.03%
C: -3.99%
year revenue
Lilly Launches End-to-End Digital Healthcare Experience through LillyDirect™
Published: 2024-01-04 (Crawled : 12:30) - prnewswire.com
LLY | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 1.22%
H: 1.78%
C: -1.72%
Lilly to Participate in J.P. Morgan Healthcare Conference
Published: 2024-01-02 (Crawled : 15:00) - prnewswire.com
LLY | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -0.43%
H: 2.12%
C: 2.03%
conference
Lilly Completes Acquisition of POINT Biopharma
Published: 2023-12-27 (Crawled : 13:30) - prnewswire.com
LLY | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -0.03%
H: 2.31%
C: 1.93%
biopharma acquisition
Purple Biotech Appoints Dr. Yael Margolin to its Board of Directors
Published: 2023-12-20 (Crawled : 13:00) - globenewswire.com
PPBT | $0.456 -1.09% -1.1% 52K
|
Manufacturing
|
| O: -5.11%
H: 3.97%
C: -4.28%
PNT | $13.68 2.63% 0.15% 0
|
|
| O: 0.12%
H: 0.0%
C: 0.0%
biotech purple
Lantheus and POINT Biopharma Announce Positive Topline Results from Pivotal SPLASH Trial in Metastatic Castration-Resistant Prostate Cancer
Published: 2023-12-18 (Crawled : 12:30) - globenewswire.com
PNT | $13.68 2.63% 0.15% 0
|
|
| O: -10.09%
H: 0.0%
C: 0.0%
LLY | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 1.61%
H: 1.14%
C: 0.57%
LNTH | News | $63.8 2.36% 2.3% 800K
|
Health Technology
|
| O: -19.87%
H: 5.04%
C: -8.75%
positive cancer biopharma topline trial results
Lilly Extends Tender Offer to Acquire POINT Biopharma to Dec. 15, 2023
Published: 2023-12-04 (Crawled : 14:30) - biospace.com/
LLY | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -1.96%
H: 0.0%
C: 0.0%
biopharma acquire
Lilly Announces the Receipt of NRC Consent in Connection with its Proposed Acquisition of POINT Biopharma
Published: 2023-11-14 (Crawled : 22:00) - prnewswire.com
PNT | $13.68 2.63% 0.15% 0
|
|
| O: -1.7%
H: 2.11%
C: 0.98%
LLY | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.44%
H: 0.0%
C: 0.0%
biopharma acquisition
POINT Biopharma Reports Third Quarter 2023 Financial Results and Provides Business Highlights
Published: 2023-11-13 (Crawled : 12:30) - globenewswire.com
PNT | $13.68 2.63% 0.15% 0
|
|
| O: -0.95%
H: 0.0%
C: 0.0%
LLY | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -0.26%
H: 4.11%
C: 3.09%
business biopharma financial results
Last 15 days Sec forms
| File Id | Form | Published Date | Transaction Date | Direction | Code | Amount Transacted | Owned Amount |
| 0001193805-23-001635 | 4 | 2023-12-20 | 2023-12-18 | Sell | S | 8974245 | 0 |
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 61% | 39% |
Top 10 Gainers
AGBA | News | $1.305 226.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
INSG | $3.03 25.21% 330K
|
Electronic Technology
KNW 4 | $0.59 -0.71% 18.64% 27K
|
Manufacturing
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
ASNS | $0.828 21.75% 17.86% 18K
|
UONE | $2.36 19.8% 16.53% 75K
|
Consumer Services
Last 48 Hours Insiders Buying
CLSD | $1.29 -2.27% -2.33% 230K
|
Health Technology
|
14:00
CDZI P 25000 | $2.255 0.22% 160K
|
Utilities
|
14:00
ETST P 39000 | $0.068 -67.14% 43K
|
Manufacturing
|
13:30
FNLC P 1275 | $22.97 3.66% 3.53% 21K
|
Finance
|
12:30
ADMQ | $0.0532 -40.18% 480K
|
|
10:30
AXR P 2400 | $20.99 -5.32% 11K
|
Finance
|
21:00
QCRH P 118 | $56.88 2.65% 23K
|
Finance
|
18:01
VUZI P 7500 | $1.225 -2.78% 410K
|
Electronic Technology
|
18:00
RMCF | $3.69 3.94% 9.5K
|
Consumer Non-Durables
|
20:10